Population based cost-effectiveness analysis of combination capacitabine and docetaxel (DC) versus single agent docetaxel (D) in the treatment of metastatic breast cancer (MBC) following an anthracycline regimen
- 1 March 2002
- journal article
- Published by Elsevier in European Journal Of Cancer
- Vol. 38 (11) , S67
- https://doi.org/10.1016/s0959-8049(02)80199-x
Abstract
No abstract availableKeywords
This publication has 0 references indexed in Scilit: